Pfizer Marks 16 Years of Annual Dividend Increases with 345th Consecutive Quarterly Dividend Payments

Today, Pfizer paid its 345th consecutive quarterly dividend, reinforcing its long-standing commitment to delivering value to shareholders. This payment to shareholders marks 16 years of annual dividend increases, demonstrating the company’s disciplined execution and focus on its capital allocation priorities.

“Our decision to increase our quarterly dividend underscores our strong financial performance, disciplined execution and our commitment to returning value to our shareholders,” said Dr. Albert Bourla, Pfizer Chairman and Chief Executive Officer.